Call 911 or your local emergency number now for a sudden stop in urine output, breathlessness at rest, chest pain, a seizure, or confusion that comes on over hours. Those signs need emergency care, not a lab appointment.
This article is educational and is not medical advice.
Most everyday tiredness, puffiness, poor appetite and broken sleep come from something other than the kidneys. A run of short nights blunts energy and mood within days. A heavy training block leaves soreness and fatigue that can last well past the session itself. Dehydration from heat, travel or a stomach bug concentrates the blood and nudges several lab numbers at once. A high-protein week, a very salty meal, a few late nights with alcohol and simple deconditioning all produce the same vague, hard-to-place feeling.
Life stage matters too. Pregnancy, perimenopause, recovery from an infection and ordinary ageing all change how a body feels and how some blood markers read on the day of the draw.
Medicines deserve a mention without naming any. Several common products, both prescribed and bought off the shelf, shift kidney markers, and some shift them only while they are being taken. Bring your current list to any appointment so the person reading your labs can account for it. Treatment decisions belong to a licensed provider.
Two long-term drivers sit above the rest. Research suggests that high blood pressure and chronic kidney disease reinforce one another, which is why blood pressure sits at the centre of kidney care 1. Blood sugar belongs in the same conversation, and screening is aimed at people whose risk is already raised by conditions of this kind rather than at everyone 2.
Here is the part that catches people out. Early chronic kidney disease is usually silent, so identification depends on blood testing rather than on how a person feels 2. Waiting for a symptom means waiting for a late signal.
Four blood markers do most of the early work, and they are read together rather than one at a time. Blood-based estimates of filtration are the standard way clinicians judge kidney function and decide whether a closer look is warranted 3.
| Marker | Why it is linked to this symptom | What a result can and cannot tell you |
|---|---|---|
| eGFR | Estimates how much blood the kidneys filter each minute, the single number that best tracks overall kidney function over time | Can show that filtration looks reduced and should be rechecked. Cannot tell you why, and it is an estimate shaped by age, sex, muscle mass and the equation your lab uses |
| Creatinine | A waste product of muscle turnover that the kidneys clear steadily, so blood levels drift up when filtration drops | Can flag a change worth repeating. Cannot separate a large, muscular body or a heavy meat meal from a filtration problem on its own |
| BUN | Nitrogen carried in urea, the waste left after protein is broken down, cleared by the kidneys | Can hint at low fluid intake, high protein load or reduced blood flow to the kidneys. Cannot stand alone as a kidney function measure, because diet and hydration move it easily |
| Cystatin C | A small protein produced at a fairly steady rate by most cells and cleared by the kidneys, so it is less tied to muscle mass | Can sharpen a filtration estimate when body composition is unusual. Cannot be read in isolation either, since thyroid status, inflammation and body composition nudge it |
Typical lab reference ranges for the three measured markers look roughly like this.
| Marker | Units | Typical lab reference range |
|---|---|---|
| Creatinine | mg/dL | roughly 0.6 to 1.3, generally lower in women than in men |
| BUN | mg/dL | roughly 7 to 20 |
| Cystatin C | mg/L | varies by assay, so read the range printed on your own report |
| eGFR | mL/min/1.73 m2 | reported as a calculated number rather than a measured one, with interpretation covered on the eGFR page |
These are typical lab reference ranges rather than personal targets, and they vary by lab, age, sex and assay. One value outside the range on one day is a starting point, not a conclusion. Kidney function is judged across time, so a repeat draw weeks or months later usually tells you more than the first one did.
An eGFR gives you an estimate of filtration rate, not a direct measurement, and for routine care that estimate is good enough to act on. Measuring filtration directly is slow and impractical outside specialist settings, so estimating equations built from a blood marker plus age and sex do the job in everyday practice 3. The eGFR page covers how the number is calculated and reported.
A falling eGFR across several draws is one of the most useful early signals there is, because it tends to move before any symptom does. A single low reading is a different thing. Dehydration on the morning of the draw, a large meat meal the night before, an acute illness, a very intense training session and a change in the equation your lab uses can all pull the number around without anything happening to the kidneys themselves.
There is a wider reason clinicians pay attention. Research suggests that reduced kidney function is associated with higher cardiovascular risk in people with chronic kidney disease, so kidney numbers and heart risk are usually assessed side by side 5.
The practical sequence is simple. The observation is a lower than expected filtration estimate. The possible meanings range from a transient effect on the day through to a genuine reduction in function. The next step is a repeat draw under better conditions and a conversation with a clinician who can see the rest of your panel and your history.
Creatinine is usually checked first because it is inexpensive, sits on almost every basic panel, and feeds directly into the eGFR calculation that guides decisions 3. It comes from the normal daily turnover of muscle, and the kidneys clear it at a fairly constant rate, so blood levels rise as filtration falls. The Creatinine page explains the measurement in more detail.
Its weakness is the same as its strength. Because creatinine comes from muscle, how much muscle you carry changes the number. A heavily muscled lifter and a frail older adult can show the same creatinine while filtering very differently. Sex, age, limb loss, a high meat intake, creatine supplementation and a dehydrated draw all shift it. That is why a creatinine value slightly above the standard range in someone who trains hard is a reason to look again rather than a conclusion about the kidneys.
Research suggests that detection of chronic kidney disease has improved as filtration estimates have been refined beyond creatinine alone, which is why a second marker is increasingly added when the picture is unclear 4. A result above the standard range is best described as suboptimal and worth discussing with a clinician, particularly if it has moved over consecutive panels.
BUN adds information about hydration, protein load and blood flow, which creatinine alone handles poorly. Urea is made in the liver when protein is broken down, then cleared by the kidneys, so the blood level reflects both what is coming in and how well it is being cleared out. The BUN page sets out the basics.
BUN climbs when fluid intake is low, when protein intake is high, when the body is in a catabolic state after illness or injury, and when blood flow to the kidneys drops. It falls with a low protein intake, in pregnancy, with overhydration and in some liver conditions. Because it swings with diet and fluids more than creatinine does, the two read together are more informative than either alone. A pattern where BUN has risen noticeably more than creatinine often points toward a hydration or blood flow explanation rather than a change in filtration, and a clinician weighs that against everything else on the panel.
That is the honest limit of this marker. BUN is useful context, not a verdict. Nobody judges kidney function on BUN by itself.
Cystatin C becomes the more useful number when muscle mass is unusual in either direction, because it is produced at a fairly steady rate by most cells rather than by muscle. Research suggests that combining cystatin C with creatinine improves the accuracy of filtration estimates compared with creatinine alone 4. The Cystatin C page covers what the test measures.
That makes it valuable for people at both ends of the body composition range. A competitive strength athlete, someone recovering from significant muscle loss, an older adult with low muscle mass and anyone with an amputation can all have a creatinine-based estimate that misrepresents their filtration. A cystatin C based estimate removes that particular distortion.
It is not a perfect marker either. Thyroid status, inflammation and body composition can all nudge cystatin C, so it is read in context like everything else. If your creatinine-based and cystatin C based estimates disagree, that disagreement is itself information, and it is a good reason to have a clinician look at the full panel rather than one line of it.
A normal set of kidney markers is reassuring without being conclusive. Filtration estimates can sit inside the standard range early in the course of kidney disease, which is why screening is directed at people with raised risk rather than being left until symptoms arrive 7.
Blood tests also say nothing about structure. Stones, cysts, scarring and blockages are questions for imaging, and a clinician decides when imaging is warranted. A single panel cannot show what your blood pressure does across a week, how a medicine you take occasionally affects you, or whether an episode of kidney stress happened between two draws.
Symptoms are their own blind spot in the other direction. Studies suggest that symptom burden in chronic kidney disease is high and frequently under-recognised, with fatigue, itching, pain and poor sleep reported across the course of the condition 8. Formal symptom measurement is increasingly being built into kidney care so that what people actually report is recorded alongside their numbers 9. A panel and a symptom history answer different questions, and neither substitutes for the other.
Family history is the last gap. A blood panel does not know that a parent or sibling has kidney disease, and that detail changes how closely a clinician watches your results over time.
See a clinician promptly, within days rather than at your next routine visit, if you notice swelling in the ankles, legs or face that is new or getting worse, a clear drop in how much urine you pass, persistent nausea with loss of appetite, itching all over with no rash, or fatigue that has deepened steadily over weeks. Blood in the urine, flank pain that will not settle and unexplained weight loss belong in the same group.
Get emergency care, not an appointment, for a sudden stop in urine output, breathlessness at rest, chest pain, a seizure, confusion that develops over hours, or severe weakness with a known high potassium result.
Do not try to work out which condition you have from a single number. The useful move is the opposite one. Bring the trend, the symptoms and your medicine list to someone qualified to read them. Discuss every result that falls outside the standard range with a clinician or licensed provider, even when you feel completely well, and never ignore an abnormal value because you feel fine.
If you are having thoughts of self-harm, call or text 988 (US) or your local emergency number now.
All four markers come from a single blood draw. The FitScript Essential panel measures creatinine, BUN and cystatin C and reports a calculated eGFR, so you see them together rather than collecting them one appointment at a time. Membership includes 150+ biomarkers tested per year, and Atlas, FitScript's AI health advisor, explains each result in plain language and shows how it compares with your earlier draws.
That trend view is the point. A single eGFR tells you where you are standing. Three of them across a year tell you which direction you are walking, and direction is what matters most with kidney markers.
What happens next is a clinical decision, not an algorithmic one. A licensed provider reviews the panel alongside your blood pressure, your history, your medicines and your symptoms, and decides whether anything needs repeating, adding or acting on. Any treatment decision belongs to that provider.
Renal failure often shows no symptoms early on. When symptoms do appear, people describe fatigue, swelling in the ankles or face, reduced urine output, poor appetite, nausea, itching, trouble sleeping and breathlessness. Because those complaints are vague and common, blood markers such as eGFR, creatinine, BUN and cystatin C give a clearer picture, and a clinician interprets them.
Yes. Kidney function can drop a long way before anything feels different, which is why blood testing matters more than waiting for a symptom. If you have raised blood pressure, high blood sugar or a family history of kidney disease, ask a clinician how often your kidney markers should be checked.
Creatinine with a calculated eGFR is the usual first check, because it is cheap, widely available and tracks filtration over time. BUN and cystatin C add context when the picture is unclear. A clinician decides which combination makes sense for you.
Not on its own. Creatinine comes from muscle turnover, so a large muscle mass, a heavy training block, creatine use, a big meat meal or a dehydrated blood draw can all raise it. A value above the standard range is a reason to repeat the test and review it with a clinician, not a diagnosis.
Because cystatin C is not produced by muscle, it can sharpen a filtration estimate in people whose muscle mass is unusually high or low. When the two estimates disagree, that disagreement itself is useful information. The ordering decision belongs to the clinician reviewing your results.
Yes, and it is one of the most common reasons for a confusing panel. Low fluid intake concentrates the blood and can raise BUN and creatinine while lowering the calculated eGFR. Arriving well hydrated for a draw and repeating the test under better conditions often resolves the question.
That depends on your starting numbers, your blood pressure, your blood sugar and your family history, so a clinician sets the interval. What matters more than any single draw is the trend across several. Keeping your results in one place makes that trend easy to see.
Treat it as a prompt, not a verdict. Book time with a clinician, bring previous results and your current medicine list, and ask whether the test should be repeated and whether cystatin C would add clarity. Do not ignore the result, and do not try to interpret it alone.